Epirus Biopharmaceuticals said that the domestic drug regulator has
approved its copy of a top-selling arthritis treatment, paving the way
for its launch in the India early next year.
HOT STOCKS
NSE
BSE
Stay informed about the best performers in Nifty 50. Stocks whose intraday price rose from their previous close are called gainers